ResultsIQ

ResultsIQ › Latest results › Jyothy Labs Limited

Jyothy Labs Limited Q2 FY27 results deck summary

NSE: JYOTHYLAB · BSE: 532926

Results deck of 4 Nov 2026, summarised by AI from the filing.

Operating EBITDA fell to ₹19.2 cr at 2.5% (Q2 FY26: ₹118.3 cr at 16.1%) as gross margin dropped to 34.8% (Q2 FY26: 48.1%).

Key takeaways

  1. Q2 margin Operating EBITDA fell to ₹19.2 cr at 2.5% (Q2 FY26: ₹118.3 cr at 16.1%) as gross margin dropped to 34.8% (Q2 FY26: 48.1%).
  2. No numeric guidance The deck gives no numeric guidance; management only plans to improve profitability progressively through scale, mix improvement and operating leverage.
  3. Pril & Fa exit Excluding Pril & Fa, Q2 FY27 value growth was 12.4% and volume growth 8.1%, against reported revenue growth of 3.3%.
  4. Home Care without Pril Home Care without Pril grew 15.3% in Q2 FY27 while Home Care with Pril declined 7.1%.
  5. Input inflation Commodity inflation stayed elevated across crude-linked and packaging inputs, creating significant pressure on margins.

Original filing on BSE

Jyothy Labs Limited Q2 FY27 results

As filed: Revenue ₹760 cr (+3% year on year), EBITDA ₹19.2 cr (−84% year on year), PAT ₹10.6 cr (−88% year on year), EBITDA margin 2.5% (−1,000 bps).

The Q2 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹773 cr (+3% year on year), EBITDA ₹64.7 cr (−48% year on year), PAT ₹47.6 cr (−51% year on year), EBITDA margin 8.4% (−828 bps). Score 9 of 100, Below trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 828 bps year on year. Other income 27% of PBT. Profit fell 29% from last quarter. Share price after the results: −4.4% in 30 days (Nifty 500: −3.4%).
  • Q4 FY26: Revenue ₹717 cr (+8% year on year), EBITDA ₹96.8 cr (−15% year on year), PAT ₹67.5 cr (−12% year on year), EBITDA margin 13.5% (−363 bps). Score 38 of 100, Below trend. Revenue growth was above the company's own trend; EBITDA growth was well below it; profit growth was below it. EBITDA margin fell 363 bps year on year. Revenue fell 3% from last quarter. Share price after the results: −24.7% in 30 days (Nifty 500: −1.0%).
  • Q3 FY26: Revenue ₹740 cr (+5% year on year), EBITDA ₹111 cr (−4% year on year), PAT ₹81.1 cr (−7% year on year), EBITDA margin 15.0% (−137 bps). Score 40 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 137 bps year on year. Profit fell 8% from last quarter. Share price after the results: −3.1% in 30 days (Nifty 500: −5.9%).
  • Q2 FY26: Revenue ₹736 cr (0% year on year), EBITDA ₹118 cr (−14% year on year), PAT ₹88.0 cr (−16% year on year), EBITDA margin 16.0% (−279 bps). Score 21 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 279 bps year on year. Profit fell 9% from last quarter. Share price after the results: −8.7% in 30 days (Nifty 500: −0.5%).
  • Q1 FY26: Revenue ₹751 cr (+1% year on year), EBITDA ₹125 cr (−6% year on year), PAT ₹97.0 cr (−5% year on year), EBITDA margin 16.6% (−130 bps). Score 26 of 100, Below trend. Revenue and profit growth were below the company's own trend; EBITDA growth was well below it. EBITDA margin fell 130 bps year on year. Share price after the results: −2.4% in 30 days (Nifty 500: +2.4%).
  • Q4 FY25: Revenue ₹667 cr (+1% year on year), EBITDA ₹113 cr (+5% year on year), PAT ₹76.0 cr (−3% year on year), EBITDA margin 16.9% (+58 bps). Score 32 of 100, Below trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin rose 58 bps year on year. Revenue fell 5% from last quarter. Share price after the results: −5.0% in 30 days (Nifty 500: +7.7%).
  • Q3 FY25: Revenue ₹704 cr (+4% year on year), EBITDA ₹115 cr (−3% year on year), PAT ₹87.0 cr (−4% year on year), EBITDA margin 16.3% (−107 bps). Score 26 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were well below it. EBITDA margin fell 107 bps year on year. Revenue fell 4% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Jyothy Labs Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.